a new healthcare research company 
 
 

Gentium SpA

Gentium S.p.A. is public (GENT - NASDAQ) biopharmaceutical company specializing in the discovery, research, development and manufacture of active ingredients derived from natural sources as potential therapeutic agents.

Gentium operates independently as a research facility and production plant for drug substance pharmaceuticals in Villa Guardia, near Como, Italy.

Gentium™ has developed a new approach focusing R&D on drugs that could be useful in the treatment of rare diseases. We develop relationships with industrial and academic institutions to combine our pioneering research expertise with these institutions. In addition, Gentium will seek to discover further beneficial effects of its products and create pharmaceuticals with a broader range of treatment indications.

The company will increase its own marketing potential by licensing its products to international companies, with focus on US and European markets.


Gentium SpA - Piazza XX Settembre, 2
22079, Villa Guardia (CO) – Italy
V.A.T. & CF code: IT02098100130

 
DEFIBROTIDE HEPARIN UROKINASE SULGLICOTIDE